Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

5.8K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.8K
Two-Compartment Open Model: Overview01:05

Two-Compartment Open Model: Overview

183
Multicompartmental models are crucial tools in pharmacokinetics, providing a framework to understand how drugs move within the body. The two-compartment model is a crucial subtype, segmenting the body into central and peripheral compartments. The central compartment represents areas with high blood flow, such as plasma and highly perfused organs like the kidneys and liver, while the peripheral compartment signifies tissues with lower blood flow, like adipose tissue and muscle tissue.
The...
183
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

2.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Identification of novel CLK1 inhibitors by computational fragment-based ligand design, co-crystallization, chemical synthesis and structure activity relationships.

European journal of medicinal chemistry·2026
Same author

Frags2Drugs: A Novel In Silico Fragment-Based Approach to the Discovery of Kinase Inhibitors.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

New fluoxetine analogues as anti-enterovirus agents targeting 2C protein.

European journal of medicinal chemistry·2026
Same author

HTRF-based identification of small molecules targeting SARS-CoV-2 E protein interaction with ZO-1 PDZ2.

Scientific reports·2025
Same author

[Prozac 2.0 : from antidepressant to antiviral].

Virologie (Montrouge, France)·2025
Same author

Flexibility or uncertainty? A critical assessment of AlphaFold 2 pLDDT.

Structure (London, England : 1993)·2025

相关实验视频

Updated: Jul 21, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

347

一个关于对接数据共享的观点.

Samia Aci-Sèche1, Stéphane Bourg1, Pascal Bonnet1

  • 1Institut de Chimie Organique et Analytique (ICOA), UMR CNRS-Université d'Orléans 7311, Université d'Orléans BP 6759, Orléans Cedex 2, 45067, France.

Data in brief
|July 26, 2023
PubMed
概括

这项研究解决了计算药物发现中透明数据共享的需求,特别是分子对接. 它提出了虚拟选的指导方针,并探讨了增强数据共享的未来前景,以造福研究界.

关键词:
三维坐标是3D坐标.停靠的对接方式公平的原则 公平的原则文件 文件 文件这是SDF.分享 分享 分享 分享

更多相关视频

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

102
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.7K

相关实验视频

Last Updated: Jul 21, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

347
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

102
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.7K

科学领域:

  • 计算化学和药物发现
  • 生物信息学和化学信息学

背景情况:

  • 计算方法,特别是分子对接,是现代药物发现中标识别的组成部分.
  • 分子对接研究的一个重大挑战是缺乏数据可用性和可重复性.
  • 透明的数据共享对于推动药物发现研究至关重要.

研究的目的:

  • 为进行强大的虚拟查实验提出指导方针和建议.
  • 评估当前分子对接数据共享实践的现状.
  • 探索未来的战略,以改善对接研究中的数据共享.

主要方法:

  • 对分子对接和虚拟查当前实践的审查.
  • 分析现有的数据共享平台和举措.
  • 根据发现的差距和最佳实践制定建议.

主要成果:

  • 确定了对虚拟查标准化指导方针的迫切需要.
  • 突出了当前分子对接数据的可访问性和可重复性的局限性.
  • 介绍了增强数据共享的潜在途径的概述.

结论:

  • 实施虚拟选的明确指导方针可以提高数据质量和可重复性.
  • 增强和透明的分子对接数据共享对于加速药物发现至关重要.
  • 未来的努力应集中在开发和采用强大的数据共享框架上.